TrialObesity (Silver Spring, Md.)2020

Semaglutide 2.4 mg for the Treatment of Obesity: Key Elements of the STEP Trials 1 to 5.

Robert F Kushner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.